Below is a roundup of fitness news.
Britain’s first supervised drug injection approved
Britain’s first official supervised drug admission room was approved on Wednesday in a bid to reduce infectious diseases and overdoses in Scotland, which suffers from the highest point of drug-related deaths in Europe. Following similar projects in Europe, Canada and Australia, Glasgow City Council, which runs Scotland’s largest city, has approved plans for the facility that will allow others to legally consume illicit drugs under the supervision of trained professionals and supply them with blank equipment.
Namibia bans poultry imports from South Africa due to avian influenza
Namibia has suspended imports of live poultry, poultry and poultry products from South Africa following the spread of highly pathogenic avian influenza (HPAI) in the neighbouring country. The suspension is in effect until further notice, the agriculture ministry said Wednesday.
Biden plans $100 million crusade against drug-resistant ‘superbugs’
President Joe Biden will announce a $100 million research campaign Wednesday to combat deadly drug-resistant bacteria, according to a White House official. More than a million people worldwide lose their lives each year due to infections caused by antibiotic-resistant bacteria, according to the World Health Organization.
EU regulator to discuss anaesthesia threat to weight-loss drugs
The European Medicines Agency (EMA) will talk about the threat of patients taking Wegovy, Ozempic or drugs suffering safe headaches under anaesthesia that can lead to pneumonia, according to a schedule published on the regulator’s website. The regulator’s Pharmacovigilance Risk Assessment Committee (PRAC), which monitors drug side effects, will discuss this week at its series of monthly meetings a new “pneumonia aspiration and aspiration signal” related to the elegance of weight-loss and antidiabetic drugs known as GLP-1 receptor agonists. according to the document released Monday night.
Around 250,000 courses of the Paxlovid Covid pill are administered every week: Pfizer CEO
The chief executive of Pfizer Inc said Tuesday that nearly 250,000 cycles of Paxlovid, the pharmaceutical maker’s oral antiviral drug for COVID-19, were administered weekly as cases rose in the United States. Speaking at Cantor Fitzgerald’s Annual Health Care Conference, CEO Albert Bourla said the company doesn’t yet know when Paxlovid, recently distributed through the government, will get approval to be sold in the U. S. advertising market.
Consulting firm McKinsey to pay $230 million for new U. S. opioid regulationsU. S.
The consulting firm McKinsey
Cough syrup deaths trigger crackdown in U. S. U. S. Against Toxic Testing
The U. S. FDA The U. S. government is cracking down on lax testing practices by dozens of fitness product makers following many deaths from infected cough syrups, according to a Reuters regulatory alert investigation. The Food and Drug Administration rebuked at least 28 corporations this year, saying it didn’t turn out that ingredients used in over-the-counter drugs and customer products were sufficiently tested for ethylene glycol (EG) and diethylene glycol (DEG) toxins, according to a Reuters investigation of firm import alerts and warning letters to manufacturers.
Edwards Lifesciences cooperates with EU antitrust regulators
Edwards Lifesciences is competing with EU antitrust regulators after it raided one of its facilities in an EU country a week ago, U. S. medical device maker said on Tuesday. U. S. Edwards Lifesciences shares had fallen 2. 5% ahead of the market after Reuters published a report that listed two other people with direct knowledge of the EU raid. Stocks have rallied and are now up 0. 8%.
Sudanese warn cholera, dengue are spreading
Sudanese doctors have warned that cases of cholera and dengue are spreading due to the arrival of seasonal rains and the effect of more than five months of war on a health system that was already suffering before the fighting began. cholera cases for the first time since war between rival military factions began in mid-April, and he said the first case was detected in al-Qadarif state in late August.
U. S. Adjudicates on Eli Lilly’s $176. 5 Million Loss in Teva Patent Case
Drug maker Eli Lilly on Tuesday convinced a federal judge in Massachusetts to overturn a $176. 5 million jury verdict in favor of Teva Pharmaceutical, which found that Lilly’s migraine drug, Emgality, infringed three patents similar to Teva’s rival drug, Ajovy. U. S. District Judge Allison Burroughs said in a post-trial ruling that Teva’s patents covering the use of antibodies to inhibit peptides that cause headaches were invalid.
(With from agencies. )